Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypertension and Type 2 Diabetes-The Novel Treatment Possibilities. | Int J Mol Sci | 2022 | 35742943 | PubTator, text mining | PubMed |
| One Molecule for Mental Nourishment and More: Glucose Transporter Type 1-Biology and Deficiency Syndrome. | Biomedicines | 2022 | 35740271 | PubTator, text mining | PubMed |
| Hypoxia-inducible lentiviral gene expression in engineered human macrophages. | J Immunother Cancer | 2022 | 35728871 | PubTator, text mining | PubMed |
| Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus. | J Neuroinflammation | 2022 | 35715859 | PubTator, text mining | PubMed |
| Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification. | Int J Nanomedicine | 2022 | 35712639 | PubTator, text mining | PubMed |
| NRBF2 regulates the chemoresistance of small cell lung cancer by interacting with the P62 protein in the autophagy process. | iScience | 2022 | 35712081 | PubTator, text mining | PubMed |
| HSA-MnO2-131I Combined Imaging and Treatment of Anaplastic Thyroid Carcinoma. | Technol Cancer Res Treat | 2022 | 35702054 | PubTator, text mining | PubMed |
| The Less Well-Known Little Brothers: The SLC9B/NHA Sodium Proton Exchanger Subfamily-Structure, Function, Regulation and Potential Drug-Target Approaches. | Front Physiol | 2022 | 35694410 | PubTator, text mining | PubMed |
| Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy. | Diabetes Ther | 2022 | 35687260 | PubTator, text mining | PubMed |
| Calcineurin in development and disease. | Genes Dis | 2022 | 35685477 | PubTator, text mining | PubMed |
| A Review on the Role of Bicarbonate and Proton Transporters during Sperm Capacitation in Mammals. | Int J Mol Sci | 2022 | 35683013 | PubTator, text mining | PubMed |
| Combinatorial Therapy of Cancer: Possible Advantages of Involving Modulators of Ionic Mechanisms. | Cancers (Basel) | 2022 | 35681682 | PubTator, text mining | PubMed |
| PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). | Signal Transduct Target Ther | 2022 | 35680848 | PubTator, text mining | PubMed |
| Bioengineering in salivary gland regeneration. | J Biomed Sci | 2022 | 35668440 | PubTator, text mining | PubMed |
| Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease: A systematic review and network meta-analysis. | Diabetes Obes Metab | 2022 | 35665989 | PubTator, text mining | PubMed |
| Effect of Sodium-Glucose Co-transporter Protein 2 Inhibitors on Arrhythmia in Heart Failure Patients With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. | Front Cardiovasc Med | 2022 | 35665272 | PubTator, text mining | PubMed |
| The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity. | Front Physiol | 2022 | 35665228 | PubTator, text mining | PubMed |
| Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers. | Commun Biol | 2022 | 35654828 | PubTator, text mining | PubMed |
| Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor. | Sci Rep | 2022 | 35654807 | PubTator, text mining | PubMed |
| Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. | Arch Toxicol | 2022 | 35648190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=27